Skip to main content
. Author manuscript; available in PMC: 2013 May 30.
Published in final edited form as: J Am Geriatr Soc. 2010 Jan 26;58(2):324–329. doi: 10.1111/j.1532-5415.2009.02678.x

Table 1.

Percentage of Quality Indicators Satisfied Pre- and Post-intervention by group and total

Site A Site B Both Groups
Pre (N=25) Post (N=56) Pre (N=22) Post (N=34) Pre (N=47) Post (N=90)
Summary quality score 44 46 33 46* 38 46*
Individual Quality Indicators
-New memory impairment
Assessing cognition 63 67 80 31 69 53
Reviewing medications 63 71 80 56 69 65
-New dementia
Conducting neurologic exam 67 71 60 33 63 54
Screening for depression 67 100 40 83 50 92
Performing laboratory tests 0 0 0 33 0 15
-Management of dementia
Assessing functional status 30 51 10 50* 20 51*
Discussing cholinesterase inhibitor 86 67 50 71 75 68
Screening for behavioral symptoms 30 51 76 69 54 58
Managing behavioral symptoms 0 4 6 22 5 12
Discussing risk/benefits of antipsychotics 50 100 23 100* 32 100*
Counseling about driving 33 16 0 27 13 20
Counseling caregiver 5 22 0 42* 2 30*
Specifying surrogate 75 62 52 27 63 49
% referred to Alzheimer's Association 0 9 0 29* 0 17*

N= number of patients;

*

p < 0.05 comparing pre to post